JP5381718B2 - Halopolycyclic aromatic compound and method for producing the same - Google Patents
Halopolycyclic aromatic compound and method for producing the same Download PDFInfo
- Publication number
- JP5381718B2 JP5381718B2 JP2009551442A JP2009551442A JP5381718B2 JP 5381718 B2 JP5381718 B2 JP 5381718B2 JP 2009551442 A JP2009551442 A JP 2009551442A JP 2009551442 A JP2009551442 A JP 2009551442A JP 5381718 B2 JP5381718 B2 JP 5381718B2
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- ring
- aromatic compound
- halopolycyclic
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001491 aromatic compounds Chemical class 0.000 title claims description 16
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 47
- -1 halo polycyclic aromatic compound Chemical class 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 11
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- 125000004434 sulfur atom Chemical group 0.000 claims description 9
- 239000003054 catalyst Substances 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 150000001642 boronic acid derivatives Chemical class 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229910052723 transition metal Inorganic materials 0.000 claims description 4
- 150000003624 transition metals Chemical class 0.000 claims description 4
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 17
- 239000013078 crystal Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 235000011089 carbon dioxide Nutrition 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 101150003085 Pdcl gene Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 description 3
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 3
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-bis(diphenylphosphino)propane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 125000005162 aryl oxy carbonyl amino group Chemical group 0.000 description 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 2
- 125000005110 aryl thio group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000005499 phosphonyl group Chemical group 0.000 description 2
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- 125000000355 1,3-benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- UAXNXOMKCGKNCI-UHFFFAOYSA-N 1-diphenylphosphanylethyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)C(C)P(C=1C=CC=CC=1)C1=CC=CC=C1 UAXNXOMKCGKNCI-UHFFFAOYSA-N 0.000 description 1
- VRGIPEHRKNLRIY-UHFFFAOYSA-N 2,7-dibromodibenzofuran Chemical compound C1=C(Br)C=C2C3=CC=C(Br)C=C3OC2=C1 VRGIPEHRKNLRIY-UHFFFAOYSA-N 0.000 description 1
- TXLHNFOLHRXMAU-UHFFFAOYSA-N 2-(4-benzylphenoxy)-n,n-diethylethanamine;hydron;chloride Chemical compound Cl.C1=CC(OCCN(CC)CC)=CC=C1CC1=CC=CC=C1 TXLHNFOLHRXMAU-UHFFFAOYSA-N 0.000 description 1
- LRLQQERNMXHASR-UHFFFAOYSA-N 2-diphenylphosphanylpropan-2-yl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)C(C)(C)P(C=1C=CC=CC=1)C1=CC=CC=C1 LRLQQERNMXHASR-UHFFFAOYSA-N 0.000 description 1
- FWXAUDSWDBGCMN-UHFFFAOYSA-N 3-diphenylphosphanylbutan-2-yl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)C(C)C(C)P(C=1C=CC=CC=1)C1=CC=CC=C1 FWXAUDSWDBGCMN-UHFFFAOYSA-N 0.000 description 1
- MRWWWZLJWNIEEJ-UHFFFAOYSA-N 4,4,5,5-tetramethyl-2-propan-2-yloxy-1,3,2-dioxaborolane Chemical compound CC(C)OB1OC(C)(C)C(C)(C)O1 MRWWWZLJWNIEEJ-UHFFFAOYSA-N 0.000 description 1
- BCJVBDBJSMFBRW-UHFFFAOYSA-N 4-diphenylphosphanylbutyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCCP(C=1C=CC=CC=1)C1=CC=CC=C1 BCJVBDBJSMFBRW-UHFFFAOYSA-N 0.000 description 1
- BZHCVCNZIJZMRN-UHFFFAOYSA-N 9h-pyridazino[3,4-b]indole Chemical group N1=CC=C2C3=CC=CC=C3NC2=N1 BZHCVCNZIJZMRN-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BGBKFHWNRPAFDJ-UHFFFAOYSA-N C1=C(I)C=C2C3=CC=C(I)C=C3OC2=C1 Chemical compound C1=C(I)C=C2C3=CC=C(I)C=C3OC2=C1 BGBKFHWNRPAFDJ-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- REAYFGLASQTHKB-UHFFFAOYSA-N [2-[3-(1H-pyrazol-4-yl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound N1N=CC(=C1)C=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 REAYFGLASQTHKB-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 239000004305 biphenyl Chemical group 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- BMGNSKKZFQMGDH-FDGPNNRMSA-L nickel(2+);(z)-4-oxopent-2-en-2-olate Chemical compound [Ni+2].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O BMGNSKKZFQMGDH-FDGPNNRMSA-L 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 150000002940 palladium Chemical class 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical group C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- UQFSVBXCNGCBBW-UHFFFAOYSA-M tetraethylammonium iodide Chemical compound [I-].CC[N+](CC)(CC)CC UQFSVBXCNGCBBW-UHFFFAOYSA-M 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- LGQXXHMEBUOXRP-UHFFFAOYSA-N tributyl borate Chemical compound CCCCOB(OCCCC)OCCCC LGQXXHMEBUOXRP-UHFFFAOYSA-N 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Electroluminescent Light Sources (AREA)
Description
本発明は、有機合成化合物の中間体、特に有機エレクトロルミネッセンス材料の中間体として有用なハロ多環芳香族化合物、及びその製造方法に関する。 The present invention relates to an intermediate of an organic synthetic compound, in particular, a halopolycyclic aromatic compound useful as an intermediate of an organic electroluminescent material, and a method for producing the same.
カルバゾイル基が二つ置換した対称形を有するジカルバゾリル多環芳香族化合物を合成する方法において、有用な中間体が知られている。例えば、ジベンゾフランの場合、2,7−ジブロモジベンゾフランまたは2,7−ジヨードジベンゾフランを合成中間体として用いることが可能である。(例えば、非特許文献1参照。)
しかしながら、非対称形を有するジカルバゾリル多環芳香族化合物を合成する際に、これらの中間体を用いると反応制御が困難であり、一つのカルバゾイル基のみが置換した2−カルバゾリル−7−ハロジベンゾフランと同時にカルバゾイル基が2つ置換したものが副生してしまい、収率が大きく低下するという問題があった。
However, when synthesizing a dicarbazolyl polycyclic aromatic compound having an asymmetric form, it is difficult to control the reaction if these intermediates are used, and simultaneously with 2-carbazolyl-7-halodibenzofuran in which only one carbazoyl group is substituted. There was a problem that the yield of the carbazoyl group substituted was by-produced and the yield was greatly reduced.
従って、本発明は上記問題点を解決すべくなされたものであり、非対称形を有する多環芳香族化合物を高収率で合成する際に有用な中間体であるハロ多環芳香族化合物、及びその製造方法を提供することにある。 Accordingly, the present invention has been made to solve the above-described problems, and is a halopolycyclic aromatic compound that is an intermediate useful in synthesizing a polycyclic aromatic compound having an asymmetric form in a high yield, and It is in providing the manufacturing method.
上記課題は、以下の構成により解決することができた。 The above problem could be solved by the following configuration.
1.下記一般式[1]で表される化合物を用い下記一般式[2]で表されるハロ多環芳香族化合物を製造することを特徴とするハロ多環芳香族化合物の製造方法。 1. The manufacturing method of the halo polycyclic aromatic compound characterized by manufacturing the halo polycyclic aromatic compound represented by the following general formula [2] using the compound represented by the following general formula [1].
(式中、R1、R2は置換基を表し、n1、n2は0〜3の整数を表す。R3、R4はヒ ドロキシ基またはアルコキシ基を表す。R3とR4はお互いに結合して環を形成してもよい。X1は酸素原子または硫黄原子を表す。X2はハロゲン原子を表す。)
2.前記一般式[1]で表される化合物を用い、リチオ化剤を反応させた後、ボロン酸誘導体と反応させて前記一般式[2]で表されるハロ多環芳香族化合物を製造することを特徴とする前記1に記載のハロ多環芳香族化合物の製造方法。 (Wherein, R 1, R 2 represents a substituent, n1, n2 are .R 3 represents an integer of 0 to 3, R 4 is .R 3 and R 4 representing a human Dorokishi group or an alkoxy group each other bound good .X 1 to form a ring with the .X 2 representing an oxygen atom or a sulfur atom represents a halogen atom.)
2. The compound represented by the general formula [1] is reacted with a lithiating agent and then reacted with a boronic acid derivative to produce a halopolycyclic aromatic compound represented by the general formula [2]. 2. The method for producing a halopolycyclic aromatic compound as described in 1 above.
3.下記一般式[2]で表される化合物と下記一般式[3]で表される化合物を遷移金属触媒の存在下反応させて下記一般式[4]で表されるハロ多環芳香族化合物を製造することを特徴とするハロ多環芳香族化合物の製造方法。 3. A compound represented by the following general formula [2] and a compound represented by the following general formula [3] are reacted in the presence of a transition metal catalyst to produce a halopolycyclic aromatic compound represented by the following general formula [4]. A process for producing a halopolycyclic aromatic compound, characterized in that it is produced.
(式中、R1、R2は置換基を表し、n1、n2は0〜3の整数を表す。R3、R4はヒ ドロキシ基またはアルコキシ基を表す。R3とR4はお互いに結合して環を形成してもよい。X1は酸素原子または硫黄原子を表す。X2、X3はハロゲン原子を表す。Zは芳香族炭化水素環または芳香族複素環を形成するのに必要な非金属原子群を表す。)
4.下記一般式[2]で表されるハロ多環芳香族化合物。 (Wherein, R 1, R 2 represents a substituent, n1, n2 are .R 3 represents an integer of 0 to 3, R 4 is .R 3 and R 4 representing a human Dorokishi group or an alkoxy group each other binding to which may form a ring .X 1 is the .X 2, X 3 representing an oxygen atom or a sulfur atom is .Z represents a halogen atom to form an aromatic hydrocarbon ring or aromatic heterocyclic ring Represents a group of non-metallic atoms necessary for
4). A halopolycyclic aromatic compound represented by the following general formula [2].
(式中、R1、R2は置換基を表し、n1、n2は0〜3の整数を表す。R3、R4はヒ ドロキシ基またはアルコキシ基を表す。R3とR4はお互いに結合して環を形成してもよい。X1は酸素原子または硫黄原子を表す。X2はハロゲン原子を表す。)
5.下記一般式[5]で表される前記4に記載のハロ多環芳香族化合物。
5). 5. The halopolycyclic aromatic compound according to the above 4, represented by the following general formula [5].
有機合成化合物の中間体、特に有機エレクトロルミネッセンス材料の中間体として有用なハロ多環芳香族化合物は、本発明の製造方法により高収率で得られる。 A halopolycyclic aromatic compound useful as an intermediate of an organic synthetic compound, particularly as an intermediate of an organic electroluminescent material, can be obtained in a high yield by the production method of the present invention.
以下、本発明を更に詳細に述べる。 Hereinafter, the present invention will be described in more detail.
一般式[1]、一般式[2]、一般式[3]及び一般式[4]において、R1及びR2で表される置換基としては、例えば、アルキル、シクロアルキル、アルケニル、アリール、アシルアミノ、スルホンアミド、アルキルチオ、アリールチオ、ハロゲン原子、複素環、スルホニル、スルフィニル、ホスホニル、アシル、カルバモイル、スルファモイル、シアノ、アルコキシ、アリールオキシ、複素環オキシ、シロキシ、アシルオキシ、カルバモイルオキシ、アミノ、アルキルアミノ、イミド、ウレイド、スルファモイルアミノ、アルコキシカルボニルアミノ、アルコキシカルボニルアミノ、アリールオキシカルボニルアミノ、アルコキシカルボニル、アリールオキシカルボニル、カルボキシル等の各基が挙げられる。In general formula [1], general formula [2], general formula [3], and general formula [4], examples of the substituent represented by R 1 and R 2 include alkyl, cycloalkyl, alkenyl, aryl, Acylamino, sulfonamido, alkylthio, arylthio, halogen atom, heterocycle, sulfonyl, sulfinyl, phosphonyl, acyl, carbamoyl, sulfamoyl, cyano, alkoxy, aryloxy, heterocycleoxy, siloxy, acyloxy, carbamoyloxy, amino, alkylamino, Examples include imide, ureido, sulfamoylamino, alkoxycarbonylamino, alkoxycarbonylamino, aryloxycarbonylamino, alkoxycarbonyl, aryloxycarbonyl, carboxyl and the like.
X1は酸素原子、硫黄原子またはイミノ基を表し、イミノ基としてはアルキルまたはアリールで置換されたイミノ基が好ましい。これらの内、好ましいものは酸素原子である。X2で表されるハロゲン原子として、好ましいものは臭素原子である。X 1 represents an oxygen atom, a sulfur atom or an imino group, and the imino group is preferably an imino group substituted with alkyl or aryl. Of these, preferred is an oxygen atom. The halogen atom represented by X 2 is preferably a bromine atom.
R3及びR4はヒドロキシ基またはアルコキシ基を表す。R3及びR4で表されるアルコキシ基として、例えば、メトキシ基、更には環を形成するところの−OC(CH3)2C(CH3)2O−、−OCH2CH(CH3)CH2O−等が挙げられる。R3及びR4で表される基の内、好ましいものはヒドロキシ基、−OC(CH3)2C(CH3)2O−であり、より好ましくはヒドロキシ基である。R 3 and R 4 represent a hydroxy group or an alkoxy group. Examples of the alkoxy group represented by R 3 and R 4 include a methoxy group, and further —OC (CH 3 ) 2 C (CH 3 ) 2 O— and —OCH 2 CH (CH 3 ) forming a ring. CH 2 O- and the like. Among the groups represented by R 3 and R 4 , preferred are a hydroxy group, —OC (CH 3 ) 2 C (CH 3 ) 2 O—, and more preferred is a hydroxy group.
Zと共に形成される芳香族炭化水素環及び芳香族複素環としては、例えば、ベンゼン環、ビフェニル環、ナフタレン環、カルバゾール環、フラン環、チオフェン環、ピリジン環、ピリダジン環、ピリミジン環、ピラジン環、トリアジン環、ベンゾイミダゾール環、オキサジアゾール環、トリアゾール環、イミダゾール環、ピラゾール環、チアゾール環、インドール環、ベンゾイミダゾール環、ベンゾチアゾール環、ベンゾオキサゾール環、キノキサリン環、キナゾリン環、フタラジン環、カルボリン環、ジアザカルバゾール環(カルボリン環を構成する炭化水素環の炭素原子の一つが更に窒素原子で置換されている環を示す)等が挙げられる。これらの内、好ましいものはベンゼン環及びカルバゾール環である。 Examples of the aromatic hydrocarbon ring and aromatic heterocycle formed together with Z include, for example, a benzene ring, biphenyl ring, naphthalene ring, carbazole ring, furan ring, thiophene ring, pyridine ring, pyridazine ring, pyrimidine ring, pyrazine ring, Triazine ring, benzimidazole ring, oxadiazole ring, triazole ring, imidazole ring, pyrazole ring, thiazole ring, indole ring, benzimidazole ring, benzothiazole ring, benzoxazole ring, quinoxaline ring, quinazoline ring, phthalazine ring, carboline ring And a diazacarbazole ring (showing a ring in which one of the carbon atoms of the hydrocarbon ring constituting the carboline ring is further substituted with a nitrogen atom). Of these, preferred are a benzene ring and a carbazole ring.
上記の基はいずれも更に置換基によって置換されていてもよく、置換基としては、例えば、アルキル、シクロアルキル、アルケニル、アリール、アシルアミノ、スルホンアミド、アルキルチオ、アリールチオ、ハロゲン原子、複素環、スルホニル、スルフィニル、ホスホニル、アシル、カルバモイル、スルファモイル、シアノ、アルコキシ、アリールオキシ、複素環オキシ、シロキシ、アシルオキシ、カルバモイルオキシ、アミノ、アルキルアミノ、イミド、ウレイド、スルファモイルアミノ、アルコキシカルボニルアミノ、アルコキシカルボニルアミノ、アリールオキシカルボニルアミノ、アルコキシカルボニル、アリールオキシカルボニル、カルボキシル等の各基が挙げられる。 Any of the above groups may be further substituted with a substituent. Examples of the substituent include alkyl, cycloalkyl, alkenyl, aryl, acylamino, sulfonamido, alkylthio, arylthio, halogen atom, heterocycle, sulfonyl, Sulfinyl, phosphonyl, acyl, carbamoyl, sulfamoyl, cyano, alkoxy, aryloxy, heterocyclic oxy, siloxy, acyloxy, carbamoyloxy, amino, alkylamino, imide, ureido, sulfamoylamino, alkoxycarbonylamino, alkoxycarbonylamino, Examples include aryloxycarbonylamino, alkoxycarbonyl, aryloxycarbonyl, carboxyl and the like.
以下、本発明に一般式[1]、一般式[2]、一般式[3]及び一般式[4]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, typical specific examples of the compounds represented by the general formula [1], the general formula [2], the general formula [3], and the general formula [4] are shown in the present invention, but the present invention is not limited thereto. is not.
一般式[2]で表される化合物は、一般式[1]とリチオ化剤を反応させた後、ボロン酸誘導体と反応することで得ることができる。 The compound represented by the general formula [2] can be obtained by reacting the general formula [1] with a lithiating agent and then reacting with a boronic acid derivative.
リチオ化剤としては、例えば、メチルリチウム、n−ブチルリチウム、sec−ブチルリチウム、t−ブチルリチウム及びn−ヘキシルリチウム等が挙げられる。これらの内で好ましいものはn−ブチルリチウムである。ボロン酸誘導体としては、例えば、トリメチルボレート、トリブチルボレート、2−イソプロボキシ−4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン等が挙げられる。これらの内で好ましいものはトリメチルボレートである。 Examples of the lithiating agent include methyl lithium, n-butyl lithium, sec-butyl lithium, t-butyl lithium, and n-hexyl lithium. Of these, n-butyllithium is preferred. Examples of the boronic acid derivative include trimethyl borate, tributyl borate, 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and the like. Of these, trimethyl borate is preferred.
反応は通常−80〜0℃で行われるのが好ましく、−80〜−50℃で行われるのが特に好ましい。 The reaction is usually preferably performed at -80 to 0 ° C, particularly preferably at -80 to -50 ° C.
一般式[4]で表される化合物は、遷移金属触媒の存在下、一般式[2]で表される化合物と一般式[3]で表される化合物との反応で得ることができる。 The compound represented by the general formula [4] can be obtained by the reaction of the compound represented by the general formula [2] and the compound represented by the general formula [3] in the presence of a transition metal catalyst.
遷移金属触媒としては、例えば、パラジウム錯体(PdCl2、Pd(OAc)2、Pd(PPh3)4、PdCl2dppf、Pd(dba)2、Pd/C)、ニッケル錯体(NiBr2、NiBr2(PPh3)2、Ni(acac)2、Bis(1,5−cyclooctadiene)Ni(0))、亜鉛等が挙げられる。これらの内で好ましいものはパラジウム錯体である。Examples of the transition metal catalyst include palladium complexes (PdCl 2 , Pd (OAc) 2 , Pd (PPh 3 ) 4 , PdCl 2 dppf, Pd (dba) 2 , Pd / C), nickel complexes (NiBr 2 , NiBr 2). (PPh 3 ) 2 , Ni (acac) 2 , Bis (1,5-cyclotadiene) Ni (0)), zinc and the like. Among these, a palladium complex is preferable.
更に金属触媒と共に以下の化合物を添加してもよい。例えば、4級アンモニウム塩(TBAF(フッ化テトラブチルアンモニウム)、ヨウ化テトラエチルアンモニウム)、2,2′−ビピリジン、トリ(t−ブチル)ホスフィン、DPPE(Bis(diphenylphosphino)ethane)、DPPP(Bis(diphenylphosphino)propane)、DPPB(Bis(diphenylphosphino)butane)、DPPF(1,1′−Bis(diphenylphosphino)ferrocene)、PCy3(Tricyclohexylphosphine)等が挙げられる。Further, the following compounds may be added together with the metal catalyst. For example, quaternary ammonium salts (TBAF (tetrabutylammonium fluoride), tetraethylammonium iodide), 2,2′-bipyridine, tri (t-butyl) phosphine, DPPE (Bis (diphenylphosphino) ethane), DPPP (Bis ( diphenylphosphino) propane), DPPB (Bis (diphenylphosphino) butane), DPPF (1,1′-Bis (diphenylphosphino) ferrocene), PCy 3 (Tricyclohexylphosphine) and the like.
更に上記反応には塩基が用いられる。塩基としては、例えば、アルカリ金属塩(炭酸ナトリウム、炭酸カリウム、炭酸水素ナトリウム、炭酸セシウム、フッ化セシウム等)、アミン誘導体(トリエチルアミン等)等が挙げられる。 Furthermore, a base is used in the above reaction. Examples of the base include alkali metal salts (sodium carbonate, potassium carbonate, sodium hydrogen carbonate, cesium carbonate, cesium fluoride, etc.), amine derivatives (triethylamine, etc.) and the like.
反応は通常60〜130℃で行われるのが好ましく、70〜100℃で行われるのが特に好ましい。 The reaction is usually preferably carried out at 60 to 130 ° C, particularly preferably 70 to 100 ° C.
以下に実施例を挙げて本発明を具体的に説明するが、本発明の実施態様はこれに限定されるものではない。 Hereinafter, the present invention will be specifically described with reference to examples. However, the embodiment of the present invention is not limited thereto.
実施例1(比較実施例)
《化合物Dの合成》Example 1 (Comparative Example)
<< Synthesis of Compound D >>
例示化合物1−1、6.30g、カルバゾール2.9g(×0.9mol)、炭酸カリウム4.0g(×1.5mol)、Cu粉3.68g(×3mol)、脱水DMAc75mlを混合し、窒素気流下、30時間攪拌した(内温145〜147℃)。不溶分を減圧濾過し、濾液をTHFで抽出した後、減圧蒸留で溶媒を除去した。カラムクロマトグラフィー(充填剤:シリカゲル、展開液:トルエン/n−ヘキサン)で精製し、化合物Bを0.48g(収率6.0%)得た。 Exemplified compound 1-1, 6.30 g, carbazole 2.9 g (× 0.9 mol), potassium carbonate 4.0 g (× 1.5 mol), Cu powder 3.68 g (× 3 mol), dehydrated DMAc 75 ml are mixed, and nitrogen is mixed. The mixture was stirred for 30 hours under an air stream (internal temperature: 145 to 147 ° C.). Insoluble matter was filtered under reduced pressure, and the filtrate was extracted with THF, and then the solvent was removed by distillation under reduced pressure. Purification by column chromatography (filler: silica gel, developing solution: toluene / n-hexane) gave 0.48 g (yield 6.0%) of Compound B.
次に窒素気流下、化合物B、0.48g、化合物C、0.43g、エチレングリコールジメチルエーテル50ml、15%炭酸カリウム水溶液2.5ml、Pd(Pph3)40.080gを投入し、5時間還流した。反応液を水洗後、減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、化合物D、0.13g(収率20.0%)を得た。Next, under a nitrogen stream, Compound B, 0.48 g, Compound C, 0.43 g, Ethylene glycol dimethyl ether 50 ml, 15% aqueous potassium carbonate solution 2.5 ml, Pd (Pph 3 ) 4 0.080 g were charged and refluxed for 5 hours. did. The reaction solution was washed with water and filtered under reduced pressure. The resulting crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain Compound D (0.13 g, yield 20.0%).
実施例2(本発明実施例)
《化合物Dの合成》Example 2 (Example of the present invention)
<< Synthesis of Compound D >>
窒素気流下、例示化合物1−1、81.5gを脱水THF、1Lに投入し、内温25〜30℃で攪拌溶解した。次に、ドライアイス/アセトン浴で内温−72℃まで冷却した。n−BuLi(2.6M)97.1mlを内温−70℃以下、2.5時間で滴下し、1時間攪拌した。続いて、B(OCH3)360.1gを内温−70℃以下、1時間で滴下し、ドライアイス/アセトン浴を解除した。Under a nitrogen stream, 81.5 g of Exemplified Compound 1-1 was added to 1 L of dehydrated THF, and stirred and dissolved at an internal temperature of 25 to 30 ° C. Next, it was cooled to an internal temperature of −72 ° C. in a dry ice / acetone bath. 97.1 ml of n-BuLi (2.6M) was added dropwise at an internal temperature of −70 ° C. or less for 2.5 hours, and the mixture was stirred for 1 hour. Subsequently, 60.1 g of B (OCH 3 ) 3 was added dropwise at an internal temperature of −70 ° C. or less for 1 hour to release the dry ice / acetone bath.
2時間後(内温20℃)に10%HCl、l300ml(×3.3mol)を投入した。分液ロートに移し、食塩水で洗浄した。THF溶液を減圧濃縮でスラリー状とし、これにアセトニトリルを加え、析出した結晶を減圧濾過し、例示化合物2−1、50.9g(収率70%)を得た。 Two hours later (internal temperature 20 ° C.), 10% HCl, 300 ml (× 3.3 mol) was added. It was transferred to a separatory funnel and washed with brine. The THF solution was concentrated under reduced pressure to form a slurry, acetonitrile was added thereto, and the precipitated crystals were filtered under reduced pressure to obtain 50.9 g (yield 70%) of Exemplary Compound 2-1.
次に窒素気流下、例示化合物2−1、11.7g、例示化合物3−3、18.5g、炭酸カリウム10.4g、DMSO、600mlを混合し、更にPdCl2dppf1.60gを添加し、90℃付近で2時間攪拌した。水100mlを加え、析出した結晶を減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、例示化合物4−3、10g(収率57.4%)を得た。Next, Example Compound 2-1, 11.7 g, Example Compound 3-3, 18.5 g, 10.4 g of potassium carbonate, DMSO, 600 ml are mixed under a nitrogen stream, and further PdCl 2 dppf 1.60 g is added, and 90 The mixture was stirred at around 0 ° C for 2 hours. 100 ml of water was added, and the precipitated crystals were filtered under reduced pressure. The obtained crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain Exemplified Compounds 4-3 and 10 g (yield 57.4%).
次に窒素気流下、Pd(OAc)20.30g、P(But)31.0g、脱水キシレン10mlを40℃で10分攪拌した。例示化合物4−3、5.0g、例示化合物3−3、1.9g、NaOBu−t、1.2g、脱水キシレン100mlを投入し、4時間還流した。反応液を水洗後、減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、化合物D、3.60g(収率61.4%)を得た。Next, 0.30 g of Pd (OAc) 2 , 1.0 g of P (But) 3 and 10 ml of dehydrated xylene were stirred at 40 ° C. for 10 minutes under a nitrogen stream. Exemplified Compound 4-3, 5.0 g, Exemplified Compound 3-3, 1.9 g, NaOBu-t, 1.2 g, and 100 ml of dehydrated xylene were added and refluxed for 4 hours. The reaction solution was washed with water and filtered under reduced pressure. The obtained crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain 3.60 g (yield 61.4%) of Compound D.
有機エレクトロルミネッセンス材料(化合物D)の製造方法である実施例1、2から、本発明の製造方法である実施例2は、明らかに高収率であることが分かる。 From Examples 1 and 2 which are manufacturing methods of an organic electroluminescent material (compound D), it can be seen that Example 2 which is a manufacturing method of the present invention clearly has a high yield.
実施例3(本発明実施例)
《例示化合物4−8の合成》Example 3 (Example of the present invention)
<< Synthesis of Exemplified Compound 4-8 >>
窒素気流下、例示化合物1−6、47.5g、脱水THF、1Lを混ぜ、内温25〜30℃で攪拌溶解した。次に、ドライアイス/アセトン浴で内温−73℃まで冷却した。n−BuLi(2.6M)、56.6mlを内温−70℃以下、2.5時間で滴下し、1時間攪拌した。続いて、ボロン酸エステル、28gを内温−70℃以下、1時間で滴下し、ドライアイス/アセトン浴を解除した。分液ロートに移し、食塩水で洗浄した。THF溶液を減圧濃縮した。これにエタノールを加え、析出した結晶を減圧濾過し、例示化合物2−6、21.1gを得た。(収率39%)
窒素気流下、例示化合物2−6、15.4g、例示化合物3−8、15.5g、炭酸カリウム10.4g、DMSO、600mlを混合し、更にPdCl2dppf、1.60gを添加し、90℃付近で2時間攪拌した。水100mlを加え、析出した結晶を減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、例示化合物4−8、8.4g(収率47.4%)を得た。Under a nitrogen stream, Example Compound 1-6, 47.5 g, dehydrated THF, and 1 L were mixed and dissolved by stirring at an internal temperature of 25 to 30 ° C. Next, it was cooled to an internal temperature of −73 ° C. in a dry ice / acetone bath. n-BuLi (2.6 M) and 56.6 ml were added dropwise at an internal temperature of −70 ° C. or less for 2.5 hours, and the mixture was stirred for 1 hour. Subsequently, 28 g of boronic acid ester was added dropwise at an internal temperature of −70 ° C. or less for 1 hour to release the dry ice / acetone bath. It was transferred to a separatory funnel and washed with brine. The THF solution was concentrated under reduced pressure. Ethanol was added thereto, and the precipitated crystals were filtered under reduced pressure to obtain 21.1 g of exemplified compound 2-6. (Yield 39%)
Under nitrogen stream, Exemplified Compound 2-6, 15.4 g, Exemplified Compound 3-8, 15.5 g, Potassium Carbonate 10.4 g, DMSO, 600 ml were mixed, and PdCl 2 dppf, 1.60 g was added, and 90 The mixture was stirred at around 0 ° C for 2 hours. 100 ml of water was added, and the precipitated crystals were filtered under reduced pressure. The obtained crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain 8.4 g (yield 47.4%) of Exemplary Compound 4-8.
実施例4(本発明実施例)
《例示化合物4−4の合成》Example 4 (Example of the present invention)
<< Synthesis of Exemplified Compound 4-4 >>
窒素気流下、例示化合物1−3、85.5g、脱水THF、1Lを混ぜ、内温25〜30℃で攪拌溶解した。次に、ドライアイス/アセトン浴で内温−70℃まで冷却した。n−BuLi(2.6M)、97.1mlを内温−70℃以下、2.5時間で滴下し、1時間攪拌した。続いて、B(OCH3)3、60.1gを内温−70℃以下、1時間で滴下し、ドライアイス/アセトンを解除した。2時間後(内温20℃)に10%HCl、300ml(×3.3mol)を投入した。分液ロートに移し、食塩水で洗浄した。THF溶液を減圧濃縮でスラリー状とし、これにアセトニトリルを加え、析出した結晶を減圧濾過し、例示化合物2−3、39.9gを得た。(収率52%)
次に窒素気流下、例示化合物2−3、12.3g、例示化合物3−3、18.5g、炭酸カリウム10.4g、DMSO、600mlを混合し、更にPdCl2dppf、1.60gを添加し、90℃付近で2時間攪拌した。水100mlを加え、析出した結晶を減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、例示化合物4−4、8.3g(収率41%)を得た。Under a nitrogen stream, Exemplified Compound 1-3, 85.5 g, dehydrated THF, and 1 L were mixed and dissolved by stirring at an internal temperature of 25 to 30 ° C. Next, it was cooled to an internal temperature of −70 ° C. with a dry ice / acetone bath. n-BuLi (2.6M), 97.1 ml, was added dropwise at an internal temperature of −70 ° C. or less for 2.5 hours, followed by stirring for 1 hour. Subsequently, 60.1 g of B (OCH 3 ) 3 was added dropwise over 1 hour at an internal temperature of −70 ° C. or less to release dry ice / acetone. Two hours later (internal temperature 20 ° C.), 10% HCl and 300 ml (× 3.3 mol) were added. It was transferred to a separatory funnel and washed with brine. The THF solution was concentrated under reduced pressure to form a slurry, acetonitrile was added thereto, and the precipitated crystals were filtered under reduced pressure to obtain Exemplified Compound 2-3 (39.9 g). (Yield 52%)
Next, under a nitrogen stream, Example Compound 2-3, 12.3 g, Example Compound 3-3, 18.5 g, 10.4 g of potassium carbonate, DMSO, 600 ml are mixed, and PdCl 2 dppf, 1.60 g is added. The mixture was stirred at around 90 ° C. for 2 hours. 100 ml of water was added, and the precipitated crystals were filtered under reduced pressure. The obtained crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain 8.3 g (yield 41%) of Exemplary Compound 4-4.
実施例5(本発明実施例)
《例示化合物4−1の合成》Example 5 (Example of the present invention)
<< Synthesis of Exemplary Compound 4-1 >>
窒素気流下、例示化合物3−1、32.9g、例示化合物2−1、64.0g、エチレングリコールジメチルエーテル1.5L、炭酸カリウム58.0g、水350ml、Pd(Pph3)47.0gを投入し、還流12時間行った。析出した結晶を濾過、乾燥した。THF4.8Lを投入し加熱溶解し、不溶分を除去後、300mlまで濃縮し、アセトニトリル300mlを滴下し、1時間攪拌した。析出した結晶を濾過し、例示化合物4−1、40.3g(収率71.0%)を得た。Under a nitrogen stream, Example Compound 3-1, 32.9 g, Example Compound 2-1, 64.0 g, Ethylene glycol dimethyl ether 1.5 L, Potassium carbonate 58.0 g, Water 350 ml, Pd (Pph 3 ) 4 7.0 g Charged and refluxed for 12 hours. The precipitated crystals were filtered and dried. 4.8 L of THF was added and dissolved by heating. After removing insolubles, the solution was concentrated to 300 ml, 300 ml of acetonitrile was added dropwise and stirred for 1 hour. The precipitated crystals were filtered to obtain 40.3 g (yield 71.0%) of Exemplary Compound 4-1.
実施例中の各化合物の同定はMASS及びNMRスペクトルで行い、それぞれ目的化合物であることを確認した。その他の例示化合物も上記の方法に準じて合成することができる。 Each compound in the examples was identified by MASS and NMR spectra to confirm that it was the target compound. Other exemplary compounds can also be synthesized according to the above method.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009551442A JP5381718B2 (en) | 2008-01-31 | 2009-01-06 | Halopolycyclic aromatic compound and method for producing the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008020540 | 2008-01-31 | ||
JP2008020540 | 2008-01-31 | ||
JP2009551442A JP5381718B2 (en) | 2008-01-31 | 2009-01-06 | Halopolycyclic aromatic compound and method for producing the same |
PCT/JP2009/050025 WO2009096202A1 (en) | 2008-01-31 | 2009-01-06 | Halogenated polycyclic aromatic compound and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2009096202A1 JPWO2009096202A1 (en) | 2011-05-26 |
JP5381718B2 true JP5381718B2 (en) | 2014-01-08 |
Family
ID=40912555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009551442A Expired - Fee Related JP5381718B2 (en) | 2008-01-31 | 2009-01-06 | Halopolycyclic aromatic compound and method for producing the same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5381718B2 (en) |
WO (1) | WO2009096202A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102325753B (en) | 2008-12-19 | 2014-09-10 | 百时美施贵宝公司 | Carbazole carboxamide compounds useful as kinase inhibitors |
JP5623996B2 (en) * | 2010-09-21 | 2014-11-12 | 株式会社半導体エネルギー研究所 | Carbazole derivatives |
JP5856266B2 (en) * | 2010-09-21 | 2016-02-09 | 株式会社半導体エネルギー研究所 | Organic semiconductor device |
JP5831068B2 (en) * | 2011-09-13 | 2015-12-09 | コニカミノルタ株式会社 | Process for producing fused heterocyclic compound |
JP2014110276A (en) | 2012-11-30 | 2014-06-12 | Samsung Display Co Ltd | Hole transport material for organic electroluminescent element and organic electroluminescent element using the same |
US9172047B2 (en) | 2012-11-30 | 2015-10-27 | Samsung Display Co., Ltd. | Hole transport material for organic electroluminescence device and organic electroluminescence device using the same |
TW201718581A (en) | 2015-10-19 | 2017-06-01 | 英塞特公司 | Heterocyclic compounds as immunomodulators |
EP4141002A1 (en) | 2015-11-19 | 2023-03-01 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
US20170174679A1 (en) | 2015-12-22 | 2017-06-22 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
WO2017130977A1 (en) | 2016-01-29 | 2017-08-03 | 住友化学株式会社 | Composition, phosphorescent compound, and light-emitting element |
WO2017192961A1 (en) | 2016-05-06 | 2017-11-09 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
WO2017205464A1 (en) | 2016-05-26 | 2017-11-30 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
MD3472167T2 (en) | 2016-06-20 | 2023-02-28 | Incyte Corp | Heterocyclic compounds as immunomodulators |
MA45669A (en) | 2016-07-14 | 2019-05-22 | Incyte Corp | HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS |
EP3504198B1 (en) | 2016-08-29 | 2023-01-25 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
WO2018119221A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Pyridine derivatives as immunomodulators |
WO2018119266A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Benzooxazole derivatives as immunomodulators |
WO2018119236A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Triazolo[1,5-a]pyridine derivatives as immunomodulators |
US11532790B2 (en) | 2017-04-27 | 2022-12-20 | Sumitomo Chemical Company, Limited | Composition and light emitting device using the same |
CN110546781B (en) | 2017-04-27 | 2022-05-10 | 住友化学株式会社 | Light emitting element |
LT3774791T (en) | 2018-03-30 | 2023-04-11 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
EP3790877B1 (en) | 2018-05-11 | 2023-03-01 | Incyte Corporation | Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators |
CA3150434A1 (en) | 2019-08-09 | 2021-02-18 | Incyte Corporation | Salts of a pd-1/pd-l1 inhibitor |
AU2020357514A1 (en) | 2019-09-30 | 2022-04-07 | Incyte Corporation | Pyrido[3,2-d]pyrimidine compounds as immunomodulators |
JP2023500395A (en) | 2019-11-11 | 2023-01-05 | インサイト・コーポレイション | Salts and Crystal Forms of PD-1/PD-L1 Inhibitors |
US11780836B2 (en) | 2020-11-06 | 2023-10-10 | Incyte Corporation | Process of preparing a PD-1/PD-L1 inhibitor |
CN116670114A (en) | 2020-11-06 | 2023-08-29 | 因赛特公司 | Methods for preparing PD-1/PD-L1 inhibitors, and salts and crystalline forms thereof |
TW202233615A (en) | 2020-11-06 | 2022-09-01 | 美商英塞特公司 | Crystalline form of a pd-1/pd-l1 inhibitor |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002529471A (en) * | 1998-11-06 | 2002-09-10 | コモンウエルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション | Hydroboronation method |
JP2007211237A (en) * | 2005-12-28 | 2007-08-23 | Sumitomo Chemical Co Ltd | Block copolymer |
-
2009
- 2009-01-06 JP JP2009551442A patent/JP5381718B2/en not_active Expired - Fee Related
- 2009-01-06 WO PCT/JP2009/050025 patent/WO2009096202A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002529471A (en) * | 1998-11-06 | 2002-09-10 | コモンウエルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション | Hydroboronation method |
JP2007211237A (en) * | 2005-12-28 | 2007-08-23 | Sumitomo Chemical Co Ltd | Block copolymer |
Non-Patent Citations (1)
Title |
---|
JPN6013025124; Xing Xiao, et al.: Journal of Polymer Science, Part A: Polymer Chemistry 45(12), 2007, 2410-2424 * |
Also Published As
Publication number | Publication date |
---|---|
JPWO2009096202A1 (en) | 2011-05-26 |
WO2009096202A1 (en) | 2009-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5381718B2 (en) | Halopolycyclic aromatic compound and method for producing the same | |
ES2585221T3 (en) | A process for the preparation of 6- (7 - ((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -n-methyl-1-naphthamide and synthetic intermediates thereof | |
CN104447599B (en) | A kind of tetrazole heterogeneous ring compound and preparation method thereof | |
Shu et al. | Facile and controllable synthesis of multiply substituted benzenes via a formal [3+ 3] cycloaddition approach | |
JP2010235575A (en) | Method of producing nitrogen-containing condensed heterocyclic compound | |
CN109438317B (en) | Preparation method of nitrogen-alkyl (deuterated alkyl) aromatic heterocycle and alkyl (deuterated alkyl) aryl ether compound | |
CN110117237A (en) | A kind of preparation method of aromatic nitriles or alkenyl nitrile compounds | |
KR20100101315A (en) | Process for preparing phenanthridine derivatives using trifluoroacetic acid | |
JP2012188414A (en) | Improvement of method for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, intermediate of etoricoxib | |
WO2021117767A1 (en) | Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative | |
JP2008056615A (en) | Vinylethynylaryl carboxylic acid, method for producing the same, and method for producing heat cross-linking compound by using the same | |
JP2009046408A (en) | Dihalo polycyclic aromatic compound, pyrrolyl polycyclic aromatic compound and method for producing the same | |
JP7179614B2 (en) | Method for producing nitrogen-containing heterocyclic compound | |
JP5741091B2 (en) | Method for producing nitrogen-containing fused heterocyclic compound | |
JP5209426B2 (en) | Method for producing 1,2,4-oxadiazole derivative | |
CN107814757B (en) | Method for synthesizing polysubstituted pyrrole derivative | |
JP2008069122A (en) | Manufacturing method of nitrogen-containing polycyclic heterocyclic compound | |
KR101845935B1 (en) | preparation method of pyridoisoindole derivatives | |
JP5505450B2 (en) | Method for producing nitrogen-containing polycyclic heterocyclic compound | |
CN106083649B (en) | A kind of synthetic method of the Cyclohexadiene derivatives of 3,5 diaryl, 2,6,6 tricyano, 1 imino group 2,4 | |
KR20160074488A (en) | Monoarylation of aromatic amines | |
JP6532737B2 (en) | Process for producing heteroacene compound | |
JP2013053120A (en) | New compound | |
JP5396997B2 (en) | Method for producing nitrogen-containing fused heterocyclic compound | |
JP5900675B2 (en) | Method for producing pyrrolyl polycyclic aromatic compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110614 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20110818 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130528 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130725 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130725 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130903 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130916 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5381718 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |